Product
Benserazide
1 clinical trial
2 indications
Indication
Beta Thalassemia IntermediaIndication
Sickle Cell DiseaseClinical trial
A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell DiseaseStatus: Recruiting, Estimated PCD: 2024-12-31